Bruno Vellas

M.D., PhD

Bruno Vellas is the chair of the Gérontopôle & Department of Geriatric Internal Medicine at the Toulouse University Hospital and is member of INSERM UMR 1027. He studied medicine in Toulouse and received the degree of Doctor of Medicine in 1987 and a PhD in Pysiopathology in 1990. His main interests are: development of aging and geriatric clinical research and care. He is the author and co-author of more than 869 publications in peer review journals since 1987, Index H: 81. Since 2016, he is titular member of the French National Academy of Medicine, Officier de la Légion d’Honneur, and was recipient of the Palmes Académiques in 2016. He is the chair of the WHO Collaborating Center for Frailty, Clinical Research and Geriatric Training since September 2017.In addition, Bruno VELLAS was invited to participate in the Evaluation Committee of WHO’s Global Strategy on Ageing and Health 2016-2020. He is also Member of WHO’s Advisory Committee for Health Research and Innovation (ACHRI), as well as Member of the Hellenic Initiative Against Alzheimer’s (HIAA) International Advisory Committee (IAC).Lastly, Bruno VELLAS is Principal Investigator of the INSPIRE program in the field of Geosciences.

Eleni Petridou

M.D., M.P.H. (Harvard), PhD

Eleni Petridou was born in Athens, Greece and graduated from the Medical School of the National & Kapodistrian University of Athens in 1976. She is a board-certified pediatrician (1982) and Social Medicine practitioner (1988), a Harvard School of Public Health graduate (M.P.H., Maternal and Child Health, 1986) further focusing in Epidemiology (Tufts University, 1986). Currently, she is a Professor of Preventive Medicine and Epidemiology and Director of the Centre for Research and Prevention of Injuries (CEREPRI) in the Department of Hygiene, Epidemiology and Medical Statistics of the Athens Medical School; she holds joined research appointments with the First Cardiology Department of the Athens University Medical School as a consultant in longevity issues and the Department of Clinical Epidemiology, Karolinska Institute, Sweden collaborating on an ad hoc basis with the Department of Medical Epidemiology and Biostatistics of the same University. She held Research Fellow appointments in the Departments of Epidemiology and Maternal/Child Health of the Harvard School of Public Health; served as a member of the Supervising Committee of the Injury Control Research Centre of the same University; has been a World Health Organization collaborator and coordinator of the OUTCOMES Working Group of Childhood Leukemia International Consortium (CLIC).

George Intas

Nursing and Healthcare management, and self-teaching at the Hellenic Open University (EAP), School of Social Sciences

George Intas graduated from the National and Kapodistrian University of Athens, Faculty of Nursing at 2005. He has two masters. The first one is on clinical nursing with specialty  in emergency and intensive care (National and Kapodistrian University of Athens, 2007) and the other one is in healthcare management (Hellenic Open University, 2012). He also has a Doctoral Degree (Ph.D), from the National and Kapodistrian University of Athens, Faculty of Nursing (Title: Type of management of severely ill patients and their outcome, Degree: Excellent). He has professional experience in both the private and public healthcare sector exceeding 10 years. He has worked as a nurse in medical departments, in the Emergency Department and in the Intensive Care Unit. The last 4 years he worked as a head nurse in the ultrasound and medical department and nowadays he is a senior manager of Nursing Staff of the General Hospital of Nikaia Agios Panteleimon, Athens. His academic experience is characterized by several hours of teaching in Undergraduate and Postgraduate Programs of Nursing and Healthcare management, and self-teaching at the Hellenic Open University (EAP), School of Social Sciences, MSc, Department of Health Administration. This academic experience is complemented by active participation in research conferences and workshops that support the broader field of health and health policies. His research work includes over 50 publications (≈20 Greek and 37 Foreign Languages). His work is supplemented by the writing of 5 chapters in books. All the above publications cover the period 2007-2019 and include a variety of topics such as nursing, public health, health education, health policies and more generally, topics related to quality of care and healthcare.

Quincy M. Samus

Associate Professor, Director, Translational Aging Services Core, Department of Psychiatry and Behavioural Sciences, Johns Hopkins University School of Medicine

Dr. Samus is an Associate Professor in the Department of Psychiatry and Behavioural Sciences and the founding Director of the Translational Aging Services Core in the Department of Psychiatry. As an applied gerontologist trained in interventional health services research and epidemiology, the goal of her work is to improve dementia care quality and outcomes through translation of evidence-based practices to meet the needs of patients, families and providers in real world settings. She has contributed to the advancement of several areas of research, including work to advance the understanding the multidimensional care needs of persons with dementia and their families, identification of gaps in dementia care quality, the development and implementation of innovation and practical community-based dementia care models, and building dementia care capacity in the workforce and in resource-scarce settingsShe has led several large federally funded dementia-related projects in the U.S. including the Maximising Independence  at Home trial (MIND at Home), which is testing a home-based dementia care coordination program, and the Making Engagement Meaningful through Organized Routine Interaction (MEMORI) Corps trials, which is evaluating the impact of an activity-based senior companion care program for persons living with dementia.

Dimitris Avramopoulos

M.D. Ph.D., Dept. of Genetic Medicine and Psychiatry, Johns Hopkins University


Dimitris Avramopoulos graduated from the Medical school of Athens in 1990. He has been working at Johns Hopkins University since 2001. He has been a preceptor for the doctoral program of the Department of Genetic Medicine at Johns Hopkins since 2004. He also is a visiting professor in the 1st Department of Psychiatric Clinic of the University of Athens and a register elector for the evaluation of faculty promotions in the registry APELLA in Greece. His Laboratory at Johns Hopkins is researching the genetic causes of dementia and psychiatric disease through diverse approaches, from association and linkage to gene regulation high throughput sequencing and bioinformatics. In the recent years both the wet lab and analysis sides of his research have focused in gene regulation and expression, from in vitro assays and high throughput enhancer screening to 3D chromatin conformation analysis and genome editing. They currently use induced pluripotent stem cells to model the consequences of disease associated variation after editing and differentiation to neuronal cells. He has published extensively on all these subjects reaching 139 highly cited papers.

Notis Paraskevopoulos

Actor, Theater Director and a Postgraduate Student at the University of Hull on the subject of dementia

Notis Paraskevopoulos is an actor, theater director and a Postgraduate Student at the University of Hull on the subject of dementia. He is the co-founder of Seveneleven Company with the main scope being the production of theatrical plays and the creation and implementation of recreational programs for elders and people living with dementia. Alongside his partner Mrs. Konstantina Maltezou, he has developed and implements the thāllo project, an original support and recreation program for vulnerable groups, especially targeted on elders and people living with dementia on and off care home environments. He is the writer of the book “365 days close to the elders” a publication of the thāllo method, including over 2.500 stimuli and activities for elders and people living with dementia as well as 103 explanatory diagrams of the method. Seveneleven collaborates with the Museum of Cycladic Arts, the Museum of Modern Arts and the Chios Music Festival devising an intergenerational program. Seveneleven Company has been supported by renowned organizations like the Stavros Niarchos Foundation, the TIMA Foundation and the Basilis & Eliza Goulandris Foundation. You can learn more about the company and its projects at and For a short video of our work visit

Panagiotis Kormas

M.D., Orthopaedic Surgeon


Panagiotis Kormas, M.D., is an orthopaedic surgeon, living in Athens, where he maintains his office and runs his private practice. He completed his orthopaedic residency at KAT General Hospital of Atticawhere he also undertook an internship in microsurgery. Beyond his Medical Degree and Specialty studies, he attended yearly University seminars in Social Medicine and Occupational Medicine. Until recently, he was a member of the Central Board of Health (KESY), the advisory body related to the structure and operation of the National Health System. He has also served as vice-president of the National Emergency Center (EKAV), where he managed matters of education and promotion of Primary Health Care. Currently, in addition to his medical and surgical practice, he is also a Special Administration Counselor on health issues and a Medical Services Coordinator atETHNIKI Hellenic General Insurance Company. In parallel,he isactively involved in research as a Medical Adviser in The Bioinformatics and Human Electrophysiology Lab (BiHELab) of Ionian University and associate of the Applied Philosophy Research Laboratoryof National and Kapodistrian University of Athens. His research and scientific work has been published in various international medical journals and conference proceedings.

Costas Demetzos

Professor, Director in the Laboratory of Pharmaceutical Technology, National and Kapodistrian University of Athens

Costas Demetzos is Professor of Pharmaceutical Nanotechnology in the National and Kapodistrian University of Athens. He also serves as Director of the Laboratory of Pharmaceutical Technology and since 2008 as President of the Hellenic Pharmaceutical Society (HSP). His research interest is primarily on Pharmaceutical Nanotechnology, Physical Pharmacy, Pharmaceutical Compounding and Regulatory Aspects. He has published more than 240 research papers, two monographs, co-authored one book and edited five books. He has also received several awards. His research work has international recognition, (h-index 46; i10-index=135, google scholar). It must be mentioned that he participates as a member of Organizing Committees but also as a president of International and European scientific Conferences, while being an evaluator in many committees like the Greek Ministry of Health, the Qualification Recognition Board in Cyprus, the Greek National Scholarships Foundation, the Greek Drug Administration Office, etc. He was also an elected member of the ExCo of EUFEPS (Network Coordinator) (2014-2016). He acts as a member of the editorial board of scientific journals. In 2018 Professor Costas N. Demetzos, was honored with an award by the Order of Sciences of the Academy of Athensfor his scientific achievements in Pharmaceutical Nanotechnology. www.

Doxakis Anestakis

Head of the Department of Autopsy-Forensic Histopathology at Laboratory of Forensic Medicine in Aristotle University of Thessaloniki.

Doxakis Anestakis was born and raised in Thessaloniki. In 1996 he received his degree in Medical Laboratories from Technological Institute of Thessaloniki (BS) and in 2004 he received his degree in Medicine from Aristotle University of Thessaloniki. Also, he received a Master Degree in Health Care Management from Open University of Cyprus and a PhD in Medicine from Aristotle University of Thessaloniki (he took a scholarship to undertake the PhD thesis of the “Heraclitus II – Funding for doctoral research. NSRF 2007 – 2013”). Currently he is a Research Associate in the Laboratory of Medical Biology and Teaching & Research Fellow in the Laboratory of Forensic Medicine at Medical School in Aristotle University of Thessaloniki, and also, he is a Head of the Department of Autopsy-Forensic Histopathology at Laboratory of Forensic Medicine in Aristotle University of Thessaloniki. From 2009 he has participated in 219 National and International Congresses and has announced 194 abstracts in International and Greek Conferences. He has published 34 Scientific Papers, 33 in Internationally Recognized Journals and 1 in Greek Journal. Also, he is a Head of the Management Board of the Panhellenic Biobank from Neurological Diseases (Hellas Neuro-Bio). The purpose of this Biobank is: 1) support and promote scientific and research activity in the field of neurological and neurodegenerative diseases. 2) The promotion of posthumous donation of body organs for research purposes. 3) Promotion of cooperation between scientific and research organizations in the field of neurodegenerative and neurological diseases in general. 5) The humanitarian, social, voluntary support of mental health and dementia and in particular those suffering from degenerative diseases (Alzheimer, Frontotemporal Dementia, Vascular Dementia, Dementia with particles Lewy, dementia in Parkinson’s disease and other neurodegenerative and neurological diseases in general).

Nikos Scarmeas

Associate Professor of Neurology, Columbia University

Dr Nikos Scarmeas was born and raised in Athens Greece. After obtaining an M.D. degree from the National and Kapodistrian University of Athens (NKUA) he moved to the US and had Neurology residency training and then a 2-year clinical fellowship in Aging and Dementia at Columbia University Medical Center. He also completed a Masters degree in Biostatistics – Epidemiology at the Mailman School of Public Health at Columbia University. Dr Scarmeas joined the faculty of Columbia University in 2002. He currently shares his time between research and clinical work in the NKUA with an affiliation at Columbia University. His clinical work includes seeing elderly patients with dementias and cognitive dysfunction, supervising and teaching of Medical students and Neurology residents. His research interests have started from the topic ofcognitive reserve (i.e. how higher IQ, education, more demanding occupational attainments, or more engagement in cognitive-social-physical leisure – lifestyle activities can help elderly cope better with the damage caused to their brains by Alzheimer’s disease and aging and therefore reduce their risk for dementia and slow down their rates of cognitive and functional decline). He has also a special interest in the contribution of nutrition (in particular composite dietary patterns such as a Mediterranean-type diet and others) and physical activity in dementias and healthy cognitive aging. Dr Scarmeas has been the Principal Investigator and Co-Investigator in multiple studies funded by either the Alzheimer’s Association, the NIH and other agencies. His research has resulted in more than 180 original publications in highly esteemed journals (>11000 Scopus citations, Scopus h-index = 56) and multiple presentations in internationally acclaimed scientific conferences – meetings. He reviews for more than 200 international scientific journals and multiple international funding agencies including the Alzheimer’s Association, the NIH, the ERC, the European JPND and Horizon 2020 programs etc.

Evangelos Pappas

MD, Scientific Director of the Society for Psychosocial Research and Intervention

Dr. Pappas studied Medicine at the Aristotle University of Thessaloniki (AUTH) Medical School. He is now working as a Private Psychiatrist,  and as Scientific Director of the Society for Psychosocial Research and Intervention (SPRI), a Non-for-profit Non-Governmental Organization that operates boarding houses for people with severe Intellectual Disabilities and Mental Disorders, Day Center for  Dementia and implements programs for Frail and vulnerable social groups (Elderly, Alzheimer’s patients, people with disabilities), while at the same time working in the “Zosimades” Nursing Home and “Zographion” House of Elderly in Ioannina. He trained in London UK (King’s College National Health Service Trust, Maudsley and Bethlehem Royal Hospital, Institute of Psychiatry, Section of Brain Maturation) in Adult Developmental Disorders (Mental Retardation, Attention Deficit Hyperactivity Disorder Autistic Spectrum Disorders). He volunteers with people with intellectual disabilities and severe disabilities at the Social Welfare Center of Epirus Region «Neomartis George Foundation» and the Hellenic Protection Society & Rehabilitation of Disabled People-ELEPAP

Paraskevi Sakka

Head of the Greek National Observatory for Dementia and Alzheimer’s Disease

Dr Paraskevi Sakka graduated from the Medical School of the National and Kapodistrian University of Athens (NKUA) from which she also obtained a specialty title in Neurology and Psychiatry. She completed her training at the Cambridge University Psychiatric Hospital, UK. She obtained a Ph.D. degree from the Medical School of NKUA. Since 2003, she has been Director of the Department of Neurodegenerative Brain Diseases – Memory Clinic of Hygeia Hospital in Athens. Her clinical work is seeing elderly patients with dementia and other neurodegenerative disorders. Her research interests include pharmacological and nonpharmacological treatments of dementia and the use of Technological Innovations in monitoring and supporting patients with cognitive impairment. She has participated in numerous Greek and international projects for dementia and other degenerative brain disorders. Dr. Sakka is particularly interested in the social aspects of dementia and the burden imposed on caregivers and families. She has founded the Athens Alzheimer Association in which has been continuously elected president, since 2002. During the last years she has been active in making Dementia a Public Health priority in Greece.  Since 2015, as Head of the Greek National Observatory for Dementia and Alzheimer’s Disease, Dr. Sakka has been working towards the development and the implementation of the Greek Dementia Action Plan.

Vasilios K. Kimiskidis

MD, PhD, is Professor of Neurology & Clinical Neurophysiology and Head of the Laboratory of Clinical Neurophysiology of the Aristotle University of Thessaloniki.

Vasilios K. Kimiskidis, MD, PhD, is Professor of Neurology & Clinical Neurophysiology and Head of the Laboratory of Clinical Neurophysiology of the Aristotle University of Thessaloniki. Prof. Kimiskidis received training in Clinical Neurophysiology and Transcranial Magnetic Stimulation at the Laboratory of Clinical Neurophysiology, University of Oxford by Prof. K. R. Mills, a pioneer and authority in the field. Since 1995, he has been actively involved in the development and application of TMS–EMG and TMS–EEG techniques in the investigation of neurological diseases and epilepsy in particular. His recent research efforts focus on TMS–EEG as a means of exploring and modulating the dynamical state of epileptic neuronal networks with a view to developing biomarkers of diagnostic utility as well as optimizing neuromodulatory interventions for therapeutic purposes. He has lectured extensively on these issues as an invited speaker in numerous international congresses. He is the author of 103 papers published in peer-reviewed journals with 2578 citations and an ISI-h index of 24. He currently serves as vice-President of the Greek chapter of the International League against Epilepsy (ILAE), delegate of Greece to the International Federation of Clinical Neurophysiology (IFCN) and is a member of the Special Interest Group of IFCN on Non-invasive Brain Stimulation (NBS) Techniques

Ioannis (John) Sotiropoulos

PhD, Group Leader, ICVS Institute, School of Medicine, University of Minho, Portugal

Dr Ioannis (John) Sotiropoulos is Group Leader/FCT Investigador/Researcher C– at the ICVS Institute of Medical School, University of Minho in Portugal. His research work focuses on understanding the orchestrating role of lifetime, daily stress on the onset of Alzheimer´s disease (AD) with specific focus on the relationship between AD and depression, a stress-related disorder. His PhD studies (Heidelberg University & Max-Planck Institute of Psychiatry, Germany) focused on how stressful life experiences and chronic stress precipitates AD pathology while he gained further experience in Cell biology in the Physiology Department of UCL (UK). During his post-studies, he obtained a British Council Visiting Researcher Fellowship at the MRC Centre for Synaptic Plasticity, Bristol where he trained in electrophysiology. His work is published in high esteemed journals such as PNAS, Molecular Psychiatry, EMBO, Aging Cell, J Neuroscience. His scientific achievements are internationally recognised in the form of prizes/awards e.g. HirnligaAlzheimer Award 2009, AD/PD Young Faculty 2014 Award, Jerome Lejeune 2017 Award, Janssen Innovation Award 2017.

Agapi Sbokou

Co-owner and CEO of Phāea Resorts

Agapi Sbokou is co-owner and CEO of Phāea Resorts, a leading, privately-owned hotel company with 5 resorts in Crete. Since 2011 she is an elected member of the board of the Greek Tourism Confederation (SETE) and the Vice President of Marketing Greece, private sector’s initiative to promote Greece as a modern and exciting tourism destination. She is a member of the European Distribution Strategy Advisory Council of Marriott International and a member of the Marriott Business Council in Greece. She holds an M.B.A from Cass Business School of City University of London; a B.A. in Law from the National and Kapodistrian University of Athens; and speaks English, German, Italian and Greek.

Marina - Aggeliki Pappa

Pharmacist student, Caregiver

My name is Marina – Aggeliki Pappa and I was born in February 1991. I come from Greece and I live in the city of Ioannina. I am a pharmacist student at the National and Kapodistrian University of Athens, Greece.  As part of my studies, I completed my lab work and a one year internship in a pharmacy in Athens. I have also worked as a pharmasist assistant at multiple pharmacies for over a year. I am currently an Alzheimer caregiver for my mother (together with my father). My mother was diagnosed with Alzheimer’s in 2015, with the first symptoms appearing at the age of 51 in 2010. Those symptoms included short memory and concentration losses during her daily tasks. Since then, her condition is deteriorating at a relatively stable rate. She is now 61 years old and needs supervision and assistance for the majority of the day.

Maria-Labrini Koula


Maria-Labrini Koula, is a psychologist and a Scientific coordinator of the Day Center for people with dementia in Ioannina of the Society of Psychosocial Research and intervention and scientifically responsible of the project team in the European Research Joint action “Managing frailty. A comprehensive approach to promote a disability-free advanced age in Europe: THE ADVANTAGE Initiative». She is rained in psychotherapy – short psychodynamic interpersonal Psychotherapy at the University of Manchester and group Psychotherapy.  Since 2007, she has been working in Psychosocial rehabilitation units and maintains her personal office in the city of Ioannina. In the past she worked in the Recovery and Rehabilitation Center “Olympion” of Ioannina and in programs for counseling of unemployed and other vulnerable groups. At the same time, she was a scientific collaborator – responsible for the “home care of vulnerable groups” programme. She is a certified trainer “Train the Trainers” on Alzheimer’s issues, member of the Scientific Committee of the Hellenic Federation of Alzheimer’s and related disorders, substitute member of the Board of Directors of the Regional council of the PEDITOPSY , Epirus and Member of the Scientific Committee of KOISPE “Thyamis” of Ioannina, Thesprotia.

Gill Livingston

Professor of psychiatry, University College London, Division of Psychiatry

Gill Livingston is professor of psychiatry of older people in University College London, Division of Psychiatry, head of mental health care of older people’s research department & works clinically consultant psychiatrist, Camden &Islington NHS FT in London, UK. She leads the Lancet International Standing Commission on Dementia Prevention, Intervention and Care, launched in 2017. It contained a novel life course analysis of potentially modifiable risks in dementia and the new 2020 commission has updated this. She works in research and clinically to the commission’s strapline “Acting now on dementia prevention, intervention, and care will vastly improve living and dying for individuals with dementia and their families, and in doing so, will transform the future for society.”   Her other research includes the START project which successfully reduced  and prevented depression in carers in a randomised controlled trial, demonstrating clinical and cost effectiveness and long term effectiveness. She also researches interventions in care homes; non-pharmacological interventions for sleep in dementia and dementia and interventions in minority ethnic groups.

Savvas Christoforidis

Professor of Biological Chemistry, University of Ioannina and Head of the division of Biomedical Research of IMBB/FORTH at Ioannina

Savvas Christoforidis graduated from the University of Thessaloniki in 1990 (Degree in Chemistry with Suma cum Laude), got his PhD in Biological Chemistry in the University of Ioannina in 1996 and then moved to EMBL/Heidelberg/Germany for Post-doctoral studies in the field of Cell and Molecular Biology (group of Marino Zerial). Since 2001, he is appointed in the University of Ioannina (where he is currently Professor of Biological Chemistry) and affiliated member and head of the division of Biomedical Research of IMBB/FORTH at Ioannina (, where his group is located. In 2002, Savvas Christoforidis received the EMBO Young Investigator award ( He has participated in 25 successful grant applications, in 11 of which he was the scientific responsible. Three of the grants are European Research grants, i.e. a Marie Curie Individual Return grant (2000-2001) and two European Integrated Projects (“Endotrack” and “Pulmotension”, 2006-2010). His work has been published in high impact Journals, such as Nature, Nature Cell Biology, Cell, Journal of Cell Biology, PLoS Biology, EMBO Journal, Journal of Cell Science, and has received over 4,000 citations (in Scopus, excluding self-citations). His group studies the role of growth factor receptor signalling and membrane trafficking in vascular biology. In the HIAAD network, his group will contribute by studying the role of vascular dysfunction in the neuro-vascular relationship in dementia disorders.

Ioannis V. Zaganas

MD, PhD, Assistant Professor of Neurology, Medical School, University of Crete

Prof. Zaganas obtained his MD and PhD degrees from the University of Crete, Medical School in 1997 and 2005, respectively. He completed his Residency in Internal Medicine (2000), Psychiatry (2001) and Neurology (2005-2008) in the University Hospital of Heraklion, Crete, Greece. He has worked as a post-doctoral fellow in the Department of Psychiatry and Neurobiology, Mount Sinai School of Medicine, New York, USA (2004-2005) on the Genetic Basis and Neurobiology of Alzheimer’s Disease. Also, he performed research as an invited scientist in the Neurometabolism Unit of the University of Copenhagen, Denmark (2011). For these studies, he received scholarships from the “Alexandros Onassis” foundation and the University of Copenhagen. In addition, he served as a Consultant in the Neurology Department, University Hospital of Heraklion, Crete (2010-2011) and as a Temporary Lecturer, Assistant and Associate Professor of Neurology in the University of Crete, Medical School (2008-2013). Finally, he was appointed Assistant Professor of Neurology in the University of Crete, Medical School in January 2014. He is also in charge of the Dementia Clinic in the Neurology Department, University Hospital of Heraklion, Crete. In the past 20 years, he has published more than 50 papers in peer-reviewed journals, related to neurobiology/neurochemistry, dementia, rare neurogenetic disorders, stroke, paraneoplastic and para-infectious disorders etc.